Plus   Neg

Stock Alert: PVH Corp. Earnings Today

Apparel maker PVH Corp. (PVH) is scheduled to report fourth quarter today, April 1, after market close.

The company's brands include Calvin Klein, Tommy Hilfiger, Van Heusen, ARROW among various others.

China makes 20% of the company's global outsourcing and it has revenue exposure to China. The stock tumbled more than 60% in the past three months.

Last month, PVH had reaffirmed its fourth-quarter adjusted earnings outlook at $1.79. On average, 20 analysts polled by Thomson Reuters expect earnings of $1.81 for the quarter.

However the company had lowered its earnings outlook on GAAP basis due to an actuarial loss expected to be recognized on its retirement plans in the fourth quarter, primarily from a decrease in the discount rate in the latter part of January 2020.

The consensus estimate for quarterly revenue is at $2.5 billion.

PVH had reported positive earnings surprises in the past four quarters.

Tuesday, PVH was down $0.58 or 1.52% before closing at $37.64. It recorded a 52-week high of $134.24.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT